
TransCode Therapeutics Appoints Scientific Advisory Board Chair and Signs Research Agreement with Michigan State University
TransCode Therapeutics announced the appointment of Dr. Anna Moore as Chair of its Scientific Advisory Board and a sponsored research agreement with Michigan State University to advance its RNA-based therapeutic pipeline, particularly its lead candidate TTX-MC138 for metastatic cancer.
Read full story





















